GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
NASDAQ:INFI
Delisted

Infinity Pharmaceuticals Stock Price (Quote)

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$0.0160
+0 (+0%)
At Close: Dec 28, 2023
Forecast Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.0160 $0.0160 Thursday, 28th Dec 2023 INFI stock ended at $0.0160. During the day the stock fluctuated 0% from a day low at $0.0160 to a day high of $0.0160.
90 days $0.0115 $0.0190
52 weeks $0.0111 $0.770

Historical Infinity Pharmaceuticals prices

Date Open High Low Close Volume
2023-12-28 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-12-27 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-12-26 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-12-22 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-12-21 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-12-20 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-12-19 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-12-18 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-12-15 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-12-14 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-12-13 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-12-12 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-12-11 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-12-08 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-12-07 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-12-06 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-12-05 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-12-04 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-12-01 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-11-30 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-11-29 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-11-28 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-11-27 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-11-24 $0.0160 $0.0160 $0.0160 $0.0160 0
2023-11-22 $0.0160 $0.0160 $0.0160 $0.0160 0
Click to get the best stock tips daily for free!

About Infinity Pharmaceuticals

Infinity Pharmaceuticals Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of metastatic triple negative breast cancer and urothelial cancer; and Phase 1/1b clinical trials for the tre... INFI Profile

Golden Star

Ticker Date Change Price
FTSL Apr 16 0.304% $46.08
FCN Apr 16 0.0096% $207.62
ELV Apr 16 3.59% $506.97
ITCI Apr 05 5.20% $68.44
AKR Apr 05 1.33% $16.53
SARK Mar 28 16.44% $26.88
ARCC Mar 25 1.49% $20.12
STT Mar 19 0.578% $72.62
BK Mar 19 0.0181% $55.24
LNC Mar 18 0.221% $27.17
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT